U.S. delivers over 4 million doses of COVID vaccine for young children
Reuters
Published Jun 23, 2022 11:15AM ET
By Ahmed Aboulenein
WASHINGTON (Reuters) -The United States has already delivered more than 4 million doses of COVID-19 vaccines for children under 5 years old to sites that will administer the shots, a Department of Health and Human Services (HHS) spokesperson said on Thursday.
HHS has received about 4.3 million orders for vaccines for young children since pre-ordering began a few weeks ago, and will continue to take new orders, the spokesperson said.
"We made 10 million doses of vaccine available for ordering initially, with millions more available soon, so supply should not be a barrier to someone getting their young child vaccinated," the spokesperson told Reuters.
Delivery to vaccination sites such as pharmacies, doctors' offices and children's hospitals, began on Friday, immediately after the U.S. Food and Drug Administration granted the emergency use authorization.
The FDA authorized Moderna (NASDAQ:MRNA) Inc's two-dose vaccine for children aged six months to five years and Pfizer-BioNTech's three-shot regimen for children aged six months to four years late last week.
There were nearly 20 U.S. million children below the age of 5 as of 2019, according to data from the U.S. Census Bureau.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.